Rchr
J-GLOBAL ID：200901046017575960
Update date: Jan. 17, 2024
Fujisawa Tomomi
フジサワ トモミ | Fujisawa Tomomi
Affiliation and department：
Osaka University
About Osaka University
Search "Osaka University"
Research field (1)：
Metabolism and endocrinology
Research keywords (10)：
genetics
, nephrology
, geriatrics
, diabetology
, Internal medicine
, 遺伝学
, 腎臓病学
, 老年医学
, 糖尿病学
, 内科学
Research theme for competitive and other funds (2)：
糖尿病の病態に基づいた個別化医療の構築
Indiviualized medicine based upon pathophysiology of diabetes
MISC (214)：
Fumihiko Takeuchi, Masakuni Serizawa, Ken Yamamoto, Tomomi Fujisawa, Eitaro Nakashima, Keizo Ohnaka, Hiroshi Ikegami, Takao Sugiyama, Tomohiro Katsuya, Makoto Miyagishi, et al. Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population. DIABETES. 2009. 58. 7. 1690-1699
Fumihiko Takeuchi, Masakuni Serizawa, Ken Yamamoto, Tomomi Fujisawa, Eitaro Nakashima, Keizo Ohnaka, Hiroshi Ikegami, Takao Sugiyama, Tomohiro Katsuya, Makoto Miyagishi, et al. Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population. DIABETES. 2009. 58. 7. 1690-1699
A Novel Mouse Model for Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: Spontaneous Amelioration of Diabetes by Augmented Beta Cell Mass. Endocr J,. 2009. 56(2):227-234
A Novel Mouse Model for Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: Spontaneous Amelioration of Diabetes by Augmented Beta Cell Mass. Endocr J,. 2009. 56(2):227-234
Ken Sugimoto, Hiroshi Akasaka, Tomohiro Katsuya, Koichi Node, Tomomi Fujisawa, Izumi Shimaoka, Osamu Yasuda, Mitsuru Ohishi, Toshio Ogihara, Kazuaki Shimamoto, et al. A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. Hypertension (Dallas, Tex. : 1979). 2008. 52. 6. 1142-8
ｍore...
Books (2)：
Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin converting enzyme inhibitor in diabetic nephropathy.
Elsevier 2005
Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin converting enzyme inhibitor in diabetic nephropathy.
Elsevier 2005
Education (4)：
- 1997 Osaka University
- 1997 Osaka University Graduate School, Division of Medical Sciences
- 1989 Osaka University Faculty of Medicine Medical School
- 1989 Osaka University Faculty of Medicine
Professional career (1)：
医学博士 (大阪大学)
Work history (3)：
1999 - 2000 : 大阪大学附属病院シニア非常勤
2000 - -: - 大阪大学助手
1997 - 1999 : 日本学術振興会海外特別研究員(米国ハーバード大学ジョスリン糖尿病センター)
Association Membership(s) (5)：
日本腎臓学会
, 日本内分泌学会
, 日本糖尿病学会
, 日本老年医学会
, 日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
